ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Prestige Biopharma and Pharmapark Announce License and Supply Agreement to Commercialize Prestige's Trastuzumab Biosimilar in the Russian Federation b3cnewswire
July 08, 2019Prestige BioPharma?and?Pharmapark LLC?today announced that the two companies have entered into a binding agreement for the exclusive partnership and supply for the commercialization of Prestige BioPharma′s Trastuzumab biosimilar in the Russian Federation. -
Intas launches trastuzumab biosimilar to treat breast cancer firstwordpharma
April 11, 2019Intas Pharmaceuticals announced Wednesday that it launched its trastuzumab biosimilar, under the brand name Eleftha, in India, reported Business Standard.
Pharma Sources Insight January 2025
